Discover Grünenthal

3/15/2023

SOMERSET, N.J., and AACHEN, Germany – March 15, 2023 – Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, and Grünenthal, an international science-driven pharmaceutical company and a global leader in pain research and management, today announced their successful formulation design and clinical-phase manufacturing collaboration for an orally dosed small molecule in Grünenthal's pipeline.

Florian Dieckmann Head Global Communication

Florian Dieckmann

Head Global Communication


Grünenthal GmbH

52099 Aachen


E-Mail Florian.Dieckmann@grunenthal.com

Fabia Kehren, Head External Communications and Editorial Management

Fabia Kehren

Head of External Communication


Grünenthal GmbH

52099 Aachen


Phone +49 241 569-3269

E-Mail Fabia.Kehren@grunenthal.com